Correction: Alarcia-Lacalle et al. Oritavancin Multiple Dosing for Complex Infections: A Pharmacokinetic/Pharmacodynamic Simulation Study. Pharmaceutics 2026, 18, 628
Pharmaceutics · 24.07.2026 · 18 (8) · 912
DOI: 10.3390/pharmaceutics18080912 ↗Kurz gefasst
Korrektur in der Zeitschrift Pharmaceutics, online erschienen am 24.07.2026. Verfasst von Ana Alarcia-Lacalle und 5 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacokinetic, Nanotechnology and Gene Therapy Group (PharmaNanoGene), Faculty of Pharmacy, Lascaray Research Centre, University of the Basque Coun…. Die Arbeit nennt 1 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Basque Government.
Abstract (Originalsprache)
In the original published paper [...]
Autor:innen und Institutionen
- Pharmacokinetic, Nanotechnology and Gene Therapy Group (PharmaNanoGene), Faculty of Pharmacy, Lascaray Research Centre, University of the Basque Country EHU, Paseo de la Universidad n° 7, 01006 Vitoria-Gasteiz, Spain.
- Infectious Disease Division, Araba University Hospital, Osakidetza Basque Health Service, Francisco Leandro de Viana Kalea, 01009 Vitoria-Gasteiz, Spain.
- Microbiology, Infectious Disease, Antimicrobial Agents, and Gene Therapy, Bioaraba Health Research Institute, Jose Atxotegi Kalea s/n, 01009 Vitoria-Gasteiz, Spain.
- Department of Infectious Diseases, Hospital Clínic of Barcelona, University of Barcelona, Carrer de Villarroel, 170, 08036 Barcelona, Spain.
- Microbiology Service, Araba University Hospital, Osakidetza Basque Health Service, Francisco Leandro de Viana Kalea, 01009 Vitoria-Gasteiz, Spain.
ORCID-Profile: Ana Alarcia-Lacalle, Miguel Ángel Morán-Rodríguez, Laura Morata, Arantxa Isla, Andrés Canut-Blasco, Alicia Rodríguez-Gascón
Förderung
- Basque Government
Zitieren
APA
Alarcia-Lacalle, A., Morán-Rodríguez, M. Á., Morata, L., Isla, A., Canut-Blasco, A., & Rodríguez-Gascón, A. (2026). Correction: Alarcia-Lacalle et al. Oritavancin Multiple Dosing for Complex Infections: A Pharmacokinetic/Pharmacodynamic Simulation Study. Pharmaceutics 2026, 18, 628. Pharmaceutics, 18(8), 912. https://doi.org/10.3390/pharmaceutics18080912
Vancouver
Alarcia-Lacalle A, Morán-Rodríguez MÁ, Morata L, Isla A, Canut-Blasco A, Rodríguez-Gascón A. Correction: Alarcia-Lacalle et al. Oritavancin Multiple Dosing for Complex Infections: A Pharmacokinetic/Pharmacodynamic Simulation Study. Pharmaceutics 2026, 18, 628. Pharmaceutics. 2026;18(8):912. doi:10.3390/pharmaceutics18080912
BibTeX
@article{AlarciaLacalle2026,
author = {Alarcia-Lacalle, Ana and Morán-Rodríguez, Miguel Ángel and Morata, Laura and Isla, Arantxa and Canut-Blasco, Andrés and Rodríguez-Gascón, Alicia},
title = {Correction: Alarcia-Lacalle et al. Oritavancin Multiple Dosing for Complex Infections: A Pharmacokinetic/Pharmacodynamic Simulation Study. Pharmaceutics 2026, 18, 628},
journal = {Pharmaceutics},
year = {2026},
volume = {18},
number = {8},
pages = {912},
doi = {10.3390/pharmaceutics18080912}
}
EUVIMED